Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI158930, R21AI162006)
U.S. Department of Health & Human Services | NIH | National Institute of Nursing Research (R01NR01549)
Received: 23 August 2021
Accepted: 3 February 2022
First Online: 4 March 2022
: J.R. is co-founder of LUCA Biologics, a biotechnology company focusing on translating microbiome research into live biotherapeutics drugs for women’s health. All other authors declare that they have no competing interests.